CN101044234A - 具有减少身体脂肪活性的植物乳杆菌以及包含它们的食品 - Google Patents
具有减少身体脂肪活性的植物乳杆菌以及包含它们的食品 Download PDFInfo
- Publication number
- CN101044234A CN101044234A CNA2005800294502A CN200580029450A CN101044234A CN 101044234 A CN101044234 A CN 101044234A CN A2005800294502 A CNA2005800294502 A CN A2005800294502A CN 200580029450 A CN200580029450 A CN 200580029450A CN 101044234 A CN101044234 A CN 101044234A
- Authority
- CN
- China
- Prior art keywords
- strain
- cla
- lactobacterium plantarum
- plantarum strain
- lactobacterium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 240000006024 Lactobacillus plantarum Species 0.000 title claims abstract description 79
- 235000013965 Lactobacillus plantarum Nutrition 0.000 title claims abstract description 79
- 210000000577 adipose tissue Anatomy 0.000 title claims abstract description 43
- 235000013305 food Nutrition 0.000 title claims description 22
- 230000001603 reducing effect Effects 0.000 title abstract description 10
- 229940072205 lactobacillus plantarum Drugs 0.000 title abstract description 8
- 239000000654 additive Substances 0.000 claims abstract description 13
- 235000013376 functional food Nutrition 0.000 claims abstract description 10
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 claims description 61
- 229960004232 linoleic acid Drugs 0.000 claims description 56
- 230000001580 bacterial effect Effects 0.000 claims description 37
- 238000004519 manufacturing process Methods 0.000 claims description 25
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 19
- 229920000053 polysorbate 80 Polymers 0.000 claims description 19
- 239000000203 mixture Substances 0.000 claims description 18
- 208000008589 Obesity Diseases 0.000 claims description 14
- 238000000034 method Methods 0.000 claims description 14
- 235000020824 obesity Nutrition 0.000 claims description 14
- 201000010099 disease Diseases 0.000 claims description 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 11
- 230000000996 additive effect Effects 0.000 claims description 9
- 230000037396 body weight Effects 0.000 claims description 8
- 238000012258 culturing Methods 0.000 claims description 7
- 238000002360 preparation method Methods 0.000 claims description 7
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 6
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 6
- 229930006000 Sucrose Natural products 0.000 claims description 6
- 239000008101 lactose Substances 0.000 claims description 6
- 239000005720 sucrose Substances 0.000 claims description 6
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 5
- 239000000706 filtrate Substances 0.000 claims description 5
- 239000000758 substrate Substances 0.000 claims description 5
- 229930091371 Fructose Natural products 0.000 claims description 4
- 239000005715 Fructose Substances 0.000 claims description 4
- 239000003814 drug Substances 0.000 claims description 4
- 239000000047 product Substances 0.000 claims description 4
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 3
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 claims 2
- 244000068988 Glycine max Species 0.000 claims 2
- 235000010469 Glycine max Nutrition 0.000 claims 2
- 235000015067 sauces Nutrition 0.000 claims 2
- 240000004160 Capsicum annuum Species 0.000 claims 1
- 240000008384 Capsicum annuum var. annuum Species 0.000 claims 1
- 235000007862 Capsicum baccatum Nutrition 0.000 claims 1
- 235000019485 Safflower oil Nutrition 0.000 claims 1
- 239000001728 capsicum frutescens Substances 0.000 claims 1
- 235000013339 cereals Nutrition 0.000 claims 1
- 235000013351 cheese Nutrition 0.000 claims 1
- 230000003203 everyday effect Effects 0.000 claims 1
- 238000000855 fermentation Methods 0.000 claims 1
- 230000004151 fermentation Effects 0.000 claims 1
- 235000021110 pickles Nutrition 0.000 claims 1
- 230000001681 protective effect Effects 0.000 claims 1
- 235000005713 safflower oil Nutrition 0.000 claims 1
- 239000003813 safflower oil Substances 0.000 claims 1
- 235000021262 sour milk Nutrition 0.000 claims 1
- 241000186660 Lactobacillus Species 0.000 abstract description 13
- 229940039696 lactobacillus Drugs 0.000 abstract description 12
- 239000000463 material Substances 0.000 abstract description 7
- 235000021107 fermented food Nutrition 0.000 abstract description 3
- 239000007858 starting material Substances 0.000 abstract description 3
- 230000002401 inhibitory effect Effects 0.000 abstract description 2
- 241000304886 Bacilli Species 0.000 description 37
- 230000000694 effects Effects 0.000 description 28
- 238000012360 testing method Methods 0.000 description 25
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 21
- 239000000243 solution Substances 0.000 description 18
- 235000013336 milk Nutrition 0.000 description 17
- 239000008267 milk Substances 0.000 description 17
- 210000004080 milk Anatomy 0.000 description 17
- 241000030538 Thecla Species 0.000 description 15
- 239000002609 medium Substances 0.000 description 14
- 230000003115 biocidal effect Effects 0.000 description 13
- 239000002253 acid Substances 0.000 description 12
- 210000004027 cell Anatomy 0.000 description 12
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 12
- 241000196324 Embryophyta Species 0.000 description 11
- 235000009200 high fat diet Nutrition 0.000 description 11
- 210000000941 bile Anatomy 0.000 description 10
- KEMQGTRYUADPNZ-UHFFFAOYSA-N heptadecanoic acid Chemical compound CCCCCCCCCCCCCCCCC(O)=O KEMQGTRYUADPNZ-UHFFFAOYSA-N 0.000 description 10
- 235000015097 nutrients Nutrition 0.000 description 9
- 241000894006 Bacteria Species 0.000 description 8
- 244000005700 microbiome Species 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- 239000008186 active pharmaceutical agent Substances 0.000 description 7
- 239000011521 glass Substances 0.000 description 7
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 7
- 239000011159 matrix material Substances 0.000 description 7
- 238000004321 preservation Methods 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 235000019197 fats Nutrition 0.000 description 6
- 230000002265 prevention Effects 0.000 description 6
- 239000006041 probiotic Substances 0.000 description 6
- 235000018291 probiotics Nutrition 0.000 description 6
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 6
- 108020004465 16S ribosomal RNA Proteins 0.000 description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 5
- 239000002028 Biomass Substances 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 238000003794 Gram staining Methods 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 5
- 102000004195 Isomerases Human genes 0.000 description 5
- 108090000769 Isomerases Proteins 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 5
- 208000010040 Sprains and Strains Diseases 0.000 description 5
- 238000005238 degreasing Methods 0.000 description 5
- 235000005911 diet Nutrition 0.000 description 5
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 5
- 239000000284 extract Substances 0.000 description 5
- 229920000159 gelatin Polymers 0.000 description 5
- 235000019322 gelatine Nutrition 0.000 description 5
- 210000003734 kidney Anatomy 0.000 description 5
- 235000020778 linoleic acid Nutrition 0.000 description 5
- 239000003960 organic solvent Substances 0.000 description 5
- 239000002953 phosphate buffered saline Substances 0.000 description 5
- 230000000529 probiotic effect Effects 0.000 description 5
- 230000000007 visual effect Effects 0.000 description 5
- GKJZMAHZJGSBKD-NMMTYZSQSA-N (10E,12Z)-octadecadienoic acid Chemical compound CCCCC\C=C/C=C/CCCCCCCCC(O)=O GKJZMAHZJGSBKD-NMMTYZSQSA-N 0.000 description 4
- 229920001817 Agar Polymers 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 241000194032 Enterococcus faecalis Species 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 239000008272 agar Substances 0.000 description 4
- 230000037213 diet Effects 0.000 description 4
- 239000003995 emulsifying agent Substances 0.000 description 4
- 229940032049 enterococcus faecalis Drugs 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 210000000936 intestine Anatomy 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 150000002632 lipids Chemical class 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 230000004083 survival effect Effects 0.000 description 4
- 238000009631 Broth culture Methods 0.000 description 3
- 239000001828 Gelatine Substances 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 3
- 239000001888 Peptone Substances 0.000 description 3
- 108010080698 Peptones Proteins 0.000 description 3
- 241000186428 Propionibacterium freudenreichii Species 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 239000007853 buffer solution Substances 0.000 description 3
- 239000004202 carbamide Substances 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 210000000918 epididymis Anatomy 0.000 description 3
- 201000010063 epididymitis Diseases 0.000 description 3
- 229940050410 gluconate Drugs 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 235000019319 peptone Nutrition 0.000 description 3
- 229910000160 potassium phosphate Inorganic materials 0.000 description 3
- 235000011009 potassium phosphates Nutrition 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- 239000003981 vehicle Substances 0.000 description 3
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- JBYXPOFIGCOSSB-GOJKSUSPSA-N 9-cis,11-trans-octadecadienoic acid Chemical compound CCCCCC\C=C\C=C/CCCCCCCC(O)=O JBYXPOFIGCOSSB-GOJKSUSPSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- 206010018910 Haemolysis Diseases 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- UWHZIFQPPBDJPM-FPLPWBNLSA-M Vaccenic acid Natural products CCCCCC\C=C/CCCCCCCCCC([O-])=O UWHZIFQPPBDJPM-FPLPWBNLSA-M 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 210000001789 adipocyte Anatomy 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 229960000603 cefalotin Drugs 0.000 description 2
- GCFBRXLSHGKWDP-XCGNWRKASA-N cefoperazone Chemical compound O=C1C(=O)N(CC)CCN1C(=O)N[C@H](C=1C=CC(O)=CC=1)C(=O)N[C@@H]1C(=O)N2C(C(O)=O)=C(CSC=3N(N=NN=3)C)CS[C@@H]21 GCFBRXLSHGKWDP-XCGNWRKASA-N 0.000 description 2
- 229960004682 cefoperazone Drugs 0.000 description 2
- VUFGUVLLDPOSBC-XRZFDKQNSA-M cephalothin sodium Chemical compound [Na+].N([C@H]1[C@@H]2N(C1=O)C(=C(CS2)COC(=O)C)C([O-])=O)C(=O)CC1=CC=CS1 VUFGUVLLDPOSBC-XRZFDKQNSA-M 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 229940108924 conjugated linoleic acid Drugs 0.000 description 2
- 235000013365 dairy product Nutrition 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- XHCADAYNFIFUHF-TVKJYDDYSA-N esculin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)O)=CC2=C1OC(=O)C=C2 XHCADAYNFIFUHF-TVKJYDDYSA-N 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 238000004817 gas chromatography Methods 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 230000008588 hemolysis Effects 0.000 description 2
- 238000005984 hydrogenation reaction Methods 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 150000002475 indoles Chemical class 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 239000011630 iodine Substances 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- BTNMPGBKDVTSJY-UHFFFAOYSA-N keto-phenylpyruvic acid Chemical compound OC(=O)C(=O)CC1=CC=CC=C1 BTNMPGBKDVTSJY-UHFFFAOYSA-N 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000007403 mPCR Methods 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 229960005190 phenylalanine Drugs 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000012925 reference material Substances 0.000 description 2
- 238000009781 safety test method Methods 0.000 description 2
- 238000007127 saponification reaction Methods 0.000 description 2
- 238000012882 sequential analysis Methods 0.000 description 2
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000004114 suspension culture Methods 0.000 description 2
- UWHZIFQPPBDJPM-BQYQJAHWSA-N trans-vaccenic acid Chemical compound CCCCCC\C=C\CCCCCCCCCC(O)=O UWHZIFQPPBDJPM-BQYQJAHWSA-N 0.000 description 2
- 230000035899 viability Effects 0.000 description 2
- 229960003487 xylose Drugs 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- PJVXUVWGSCCGHT-ZPYZYFCMSA-N (2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal;(3s,4r,5r)-1,3,4,5,6-pentahydroxyhexan-2-one Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O.OC[C@@H](O)[C@@H](O)[C@H](O)C(=O)CO PJVXUVWGSCCGHT-ZPYZYFCMSA-N 0.000 description 1
- NWXMGUDVXFXRIG-WESIUVDSSA-N (4s,4as,5as,6s,12ar)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide Chemical compound C1=CC=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]4(O)C(=O)C3=C(O)C2=C1O NWXMGUDVXFXRIG-WESIUVDSSA-N 0.000 description 1
- XUCIJNAGGSZNQT-JHSLDZJXSA-N (R)-amygdalin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O[C@@H](C#N)C=2C=CC=CC=2)O1 XUCIJNAGGSZNQT-JHSLDZJXSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- UXFQFBNBSPQBJW-UHFFFAOYSA-N 2-amino-2-methylpropane-1,3-diol Chemical compound OCC(N)(C)CO UXFQFBNBSPQBJW-UHFFFAOYSA-N 0.000 description 1
- 239000001903 2-oxo-3-phenylpropanoic acid Substances 0.000 description 1
- BGNGWHSBYQYVRX-UHFFFAOYSA-N 4-(dimethylamino)benzaldehyde Chemical compound CN(C)C1=CC=C(C=O)C=C1 BGNGWHSBYQYVRX-UHFFFAOYSA-N 0.000 description 1
- OTLNPYWUJOZPPA-UHFFFAOYSA-N 4-nitrobenzoic acid Chemical compound OC(=O)C1=CC=C([N+]([O-])=O)C=C1 OTLNPYWUJOZPPA-UHFFFAOYSA-N 0.000 description 1
- QSUILVWOWLUOEU-GOVZDWNOSA-N 4-nitrophenyl beta-D-glucuronide Chemical compound O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC1=CC=C([N+]([O-])=O)C=C1 QSUILVWOWLUOEU-GOVZDWNOSA-N 0.000 description 1
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- PLXMOAALOJOTIY-FPTXNFDTSA-N Aesculin Natural products OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)[C@H]1Oc2cc3C=CC(=O)Oc3cc2O PLXMOAALOJOTIY-FPTXNFDTSA-N 0.000 description 1
- GEHMBYLTCISYNY-UHFFFAOYSA-N Ammonium sulfamate Chemical compound [NH4+].NS([O-])(=O)=O GEHMBYLTCISYNY-UHFFFAOYSA-N 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 241000605902 Butyrivibrio Species 0.000 description 1
- 241000605900 Butyrivibrio fibrisolvens Species 0.000 description 1
- 238000011814 C57BL/6N mouse Methods 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- WNBCMONIPIJTSB-BGNCJLHMSA-N Cichoriin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1)c1c(O)cc2c(OC(=O)C=C2)c1 WNBCMONIPIJTSB-BGNCJLHMSA-N 0.000 description 1
- GUBGYTABKSRVRQ-CUHNMECISA-N D-Cellobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-CUHNMECISA-N 0.000 description 1
- RFSUNEUAIZKAJO-VRPWFDPXSA-N D-Fructose Natural products OC[C@H]1OC(O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-VRPWFDPXSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 150000008151 D-glucosides Chemical class 0.000 description 1
- 150000008448 D-mannosides Chemical class 0.000 description 1
- SRBFZHDQGSBBOR-SOOFDHNKSA-N D-ribopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@@H]1O SRBFZHDQGSBBOR-SOOFDHNKSA-N 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- 240000001624 Espostoa lanata Species 0.000 description 1
- 235000009161 Espostoa lanata Nutrition 0.000 description 1
- 102000013382 Gelatinases Human genes 0.000 description 1
- 108010026132 Gelatinases Proteins 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- 102000053187 Glucuronidase Human genes 0.000 description 1
- 108010060309 Glucuronidase Proteins 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 108010006464 Hemolysin Proteins Proteins 0.000 description 1
- 244000283207 Indigofera tinctoria Species 0.000 description 1
- -1 LA ester Chemical class 0.000 description 1
- 240000001046 Lactobacillus acidophilus Species 0.000 description 1
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 description 1
- 241000186604 Lactobacillus reuteri Species 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical class CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 102000004459 Nitroreductase Human genes 0.000 description 1
- AYRXSINWFIIFAE-UHFFFAOYSA-N O6-alpha-D-Galactopyranosyl-D-galactose Natural products OCC1OC(OCC(O)C(O)C(O)C(O)C=O)C(O)C(O)C1O AYRXSINWFIIFAE-UHFFFAOYSA-N 0.000 description 1
- 206010033307 Overweight Diseases 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- NSOXQYCFHDMMGV-UHFFFAOYSA-N Tetrakis(2-hydroxypropyl)ethylenediamine Chemical compound CC(O)CN(CC(C)O)CCN(CC(C)O)CC(C)O NSOXQYCFHDMMGV-UHFFFAOYSA-N 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 108010059993 Vancomycin Proteins 0.000 description 1
- 239000005862 Whey Substances 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 239000002390 adhesive tape Substances 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- DEDGUGJNLNLJSR-UHFFFAOYSA-N alpha-hydroxycinnamic acid Natural products OC(=O)C(O)=CC1=CC=CC=C1 DEDGUGJNLNLJSR-UHFFFAOYSA-N 0.000 description 1
- KLOHDWPABZXLGI-YWUHCJSESA-M ampicillin sodium Chemical compound [Na+].C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C([O-])=O)(C)C)=CC=CC=C1 KLOHDWPABZXLGI-YWUHCJSESA-M 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 239000003708 ampul Substances 0.000 description 1
- 229940089837 amygdalin Drugs 0.000 description 1
- YZLOSXFCSIDECK-UHFFFAOYSA-N amygdalin Natural products OCC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC(C#N)c3ccccc3 YZLOSXFCSIDECK-UHFFFAOYSA-N 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- NNDHDYDFEDRMGH-NZWBZCBHSA-N anthraniloyllycoctonine Chemical compound C([C@]12CN(C3C4(O)[C@]5(O)[C@H]6[C@@H](OC)[C@@H]([C@H](C5)OC)C[C@H]6C3([C@@H]1[C@@H]4OC)[C@@H](OC)CC2)CC)OC(=O)C1=CC=CC=C1N NNDHDYDFEDRMGH-NZWBZCBHSA-N 0.000 description 1
- 230000000416 anti-micotic effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 239000003833 bile salt Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- RTYJTGSCYUUYAL-YCAHSCEMSA-L carbenicillin disodium Chemical compound [Na+].[Na+].N([C@H]1[C@H]2SC([C@@H](N2C1=O)C([O-])=O)(C)C)C(=O)C(C([O-])=O)C1=CC=CC=C1 RTYJTGSCYUUYAL-YCAHSCEMSA-L 0.000 description 1
- 239000012159 carrier gas Substances 0.000 description 1
- 230000021164 cell adhesion Effects 0.000 description 1
- 239000013553 cell monolayer Substances 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229960002227 clindamycin Drugs 0.000 description 1
- KDLRVYVGXIQJDK-AWPVFWJPSA-N clindamycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@H](C)Cl)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 KDLRVYVGXIQJDK-AWPVFWJPSA-N 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000019628 coolness Nutrition 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 235000015140 cultured milk Nutrition 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 230000009615 deamination Effects 0.000 description 1
- 238000006481 deamination reaction Methods 0.000 description 1
- 238000004042 decolorization Methods 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 229960003276 erythromycin Drugs 0.000 description 1
- 229940093496 esculin Drugs 0.000 description 1
- AWRMZKLXZLNBBK-UHFFFAOYSA-N esculin Natural products OC1OC(COc2cc3C=CC(=O)Oc3cc2O)C(O)C(O)C1O AWRMZKLXZLNBBK-UHFFFAOYSA-N 0.000 description 1
- YGHHWSRCTPQFFC-UHFFFAOYSA-N eucalyptosin A Natural products OC1C(O)C(O)C(CO)OC1OC1C(OC(C#N)C=2C=CC=CC=2)OC(CO)C(O)C1O YGHHWSRCTPQFFC-UHFFFAOYSA-N 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 235000021050 feed intake Nutrition 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 238000012252 genetic analysis Methods 0.000 description 1
- 229960002518 gentamicin Drugs 0.000 description 1
- DLRVVLDZNNYCBX-CQUJWQHSSA-N gentiobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-CQUJWQHSSA-N 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 150000002337 glycosamines Chemical class 0.000 description 1
- 230000009422 growth inhibiting effect Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000009998 heat setting Methods 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- 239000003228 hemolysin Substances 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 125000001041 indolyl group Chemical group 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- 239000010422 internal standard material Substances 0.000 description 1
- 210000002490 intestinal epithelial cell Anatomy 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 238000006317 isomerization reaction Methods 0.000 description 1
- 229940039695 lactobacillus acidophilus Drugs 0.000 description 1
- 229940001882 lactobacillus reuteri Drugs 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 229940049918 linoleate Drugs 0.000 description 1
- 230000004130 lipolysis Effects 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- QWIZNVHXZXRPDR-WSCXOGSTSA-N melezitose Chemical compound O([C@@]1(O[C@@H]([C@H]([C@@H]1O[C@@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O)CO)CO)[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O QWIZNVHXZXRPDR-WSCXOGSTSA-N 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 210000000713 mesentery Anatomy 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 108020001162 nitroreductase Proteins 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 239000006916 nutrient agar Substances 0.000 description 1
- UWYHMGVUTGAWSP-JKIFEVAISA-N oxacillin Chemical compound N([C@@H]1C(N2[C@H](C(C)(C)S[C@@H]21)C(O)=O)=O)C(=O)C1=C(C)ON=C1C1=CC=CC=C1 UWYHMGVUTGAWSP-JKIFEVAISA-N 0.000 description 1
- 229960001019 oxacillin Drugs 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 229940049547 paraxin Drugs 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 229960002292 piperacillin Drugs 0.000 description 1
- WCMIIGXFCMNQDS-IDYPWDAWSA-M piperacillin sodium Chemical compound [Na+].O=C1C(=O)N(CC)CCN1C(=O)N[C@H](C=1C=CC=CC=1)C(=O)N[C@@H]1C(=O)N2[C@@H](C([O-])=O)C(C)(C)S[C@@H]21 WCMIIGXFCMNQDS-IDYPWDAWSA-M 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 238000003822 preparative gas chromatography Methods 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 229940107700 pyruvic acid Drugs 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 239000001022 rhodamine dye Substances 0.000 description 1
- JQXXHWHPUNPDRT-WLSIYKJHSA-N rifampicin Chemical compound O([C@](C1=O)(C)O/C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(C)/C(=O)NC=2C(O)=C3C([O-])=C4C)C)OC)C4=C1C3=C(O)C=2\C=N\N1CC[NH+](C)CC1 JQXXHWHPUNPDRT-WLSIYKJHSA-N 0.000 description 1
- 229960001225 rifampicin Drugs 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- OARRHUQTFTUEOS-UHFFFAOYSA-N safranin Chemical compound [Cl-].C=12C=C(N)C(C)=CC2=NC2=CC(C)=C(N)C=C2[N+]=1C1=CC=CC=C1 OARRHUQTFTUEOS-UHFFFAOYSA-N 0.000 description 1
- CQRYARSYNCAZFO-UHFFFAOYSA-N salicyl alcohol Chemical compound OCC1=CC=CC=C1O CQRYARSYNCAZFO-UHFFFAOYSA-N 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 229960004249 sodium acetate Drugs 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 235000010288 sodium nitrite Nutrition 0.000 description 1
- 239000012064 sodium phosphate buffer Substances 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- QTENRWWVYAAPBI-YCRXJPFRSA-N streptomycin sulfate Chemical compound OS(O)(=O)=O.OS(O)(=O)=O.OS(O)(=O)=O.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]1O.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]1O QTENRWWVYAAPBI-YCRXJPFRSA-N 0.000 description 1
- 229960005404 sulfamethoxazole Drugs 0.000 description 1
- JLKIGFTWXXRPMT-UHFFFAOYSA-N sulphamethoxazole Chemical compound O1C(C)=CC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1 JLKIGFTWXXRPMT-UHFFFAOYSA-N 0.000 description 1
- 230000000153 supplemental effect Effects 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 239000012137 tryptone Substances 0.000 description 1
- RULSWEULPANCDV-PIXUTMIVSA-N turanose Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](C(=O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O RULSWEULPANCDV-PIXUTMIVSA-N 0.000 description 1
- 238000002525 ultrasonication Methods 0.000 description 1
- 229960003165 vancomycin Drugs 0.000 description 1
- MYPYJXKWCTUITO-UHFFFAOYSA-N vancomycin Natural products O1C(C(=C2)Cl)=CC=C2C(O)C(C(NC(C2=CC(O)=CC(O)=C2C=2C(O)=CC=C3C=2)C(O)=O)=O)NC(=O)C3NC(=O)C2NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(CC(C)C)NC)C(O)C(C=C3Cl)=CC=C3OC3=CC2=CC1=C3OC1OC(CO)C(O)C(O)C1OC1CC(C)(N)C(O)C(C)O1 MYPYJXKWCTUITO-UHFFFAOYSA-N 0.000 description 1
- MYPYJXKWCTUITO-LYRMYLQWSA-O vancomycin(1+) Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C([O-])=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)[NH2+]C)[C@H]1C[C@](C)([NH3+])[C@H](O)[C@H](C)O1 MYPYJXKWCTUITO-LYRMYLQWSA-O 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/20—Products from fruits or vegetables; Preparation or treatment thereof by pickling, e.g. sauerkraut or pickles
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
- C12P7/6409—Fatty acids
- C12P7/6427—Polyunsaturated fatty acids [PUFA], i.e. having two or more double bonds in their backbone
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
- C12P7/6409—Fatty acids
- C12P7/6427—Polyunsaturated fatty acids [PUFA], i.e. having two or more double bonds in their backbone
- C12P7/6431—Linoleic acids [18:2[n-6]]
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/169—Plantarum
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
- C12R2001/25—Lactobacillus plantarum
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Mycology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Animal Behavior & Ethology (AREA)
- Nutrition Science (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- Child & Adolescent Psychology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Dairy Products (AREA)
Abstract
Description
第1条带管/基质 | 第1条带管/基质 | 第1条带管/基质 | 第1条带管/基质 | 第1条带管/基质 |
-对照 | +半乳糖 | +D-甘露糖苷 | -蜜二糖 | +D-松二糖 |
-甘油 | +D-葡萄糖 | +D-葡糖苷 | +蔗糖 | -D-来苏糖 |
-赤藻糖醇 | +D-果糖 | +葡糖胺 | +海藻糖 | -D-塔格糖 |
-D-树胶醛糖 | +D-甘露糖 | +扁桃苷 | +安茴酰牛扁碱 | -D-岩藻糖 |
+L-树胶醛糖 | -L-山梨糖 | +熊果苷 | +松三糖 | -L-岩藻糖 |
+核糖 | -鼠李糖 | +七叶苷 | -D-棉子糖 | -D-阿拉伯糖醇 |
-D-木糖 | -卫矛醇 | +水杨苷 | -阿米酮 | -L-阿拉伯糖醇 |
-L-木糖 | -肌醇 | +纤维二糖 | -糖原 | -葡糖酸酯 |
-核糖醇 | +甘露醇 | +麦芽糖 | -木糖醇 | -2-葡糖酸酯 |
-木糖苷 | +山梨糖醇 | +乳糖 | +龙胆二糖 | -5-葡糖酸酯 |
植物乳杆菌(99.3%) |
时间 | 0hr | 3hr | 6hr | 24hr |
PH7.0 | 0.032 | 0.090 | 0.597 | 7.720 |
PH4.8 | 0.036 | 0.094 | 0.374 | 6.120 |
PH4.5 | 0.028 | 0.073 | 0.262 | 5.540 |
时间 | 0hr | 3hr | 6hr | 24hr |
胆汁0.000% | 0.032 | 0.090 | 0.597 | 7.720 |
胆汁0.250% | 0.005 | 0.026 | 0.291 | 3.030 |
抗生素 | 生长抑制的直径(mm) |
氨苄青霉素 | 34 |
羧苄青霉素 | 29 |
头孢哌酮(Cefoperazone) | 22 |
头孢金素(Cephalothin) | 25 |
氯霉素 | 30 |
氯林肯霉素 | 20 |
红霉素 | 32 |
庆大霉素 | 12 |
苯甲异噁唑青霉素 | 11 |
青霉素 | 29 |
哌拉西林 | 37 |
利福平 | 24 |
链霉素 | 8 |
四环素 | 24 |
Trimethpprime/磺胺甲噁唑 | 28 |
万古霉素 | 6 |
保留时间(min) | 加入培养基中的LA浓度(ppm) | |||||
0ppm | 10ppm | 100ppm | 500ppm | 1000ppm | ||
6.867 | 十七酸 | 100 | 100 | 100 | 100 | 100 |
12.002 | CLA(c9,t11) | 8002 | 11270 | 13789 | 17549 | 1332241 |
12.332 | CLA(t10,c12) | 2397 | 2990 | 3602 | 4171 | 4093 |
13.000 | 9967 | 8158 | 7466 | 4603 | 5791 |
植物乳杆菌菌株PL62 | ||||
RT(min) | 脱脂乳(空白) | 脱脂乳 | 脱脂乳+LA盐 | 脱脂乳+LA+吐温-80 |
6.859 | 414941 | 429862 | 313101 | 471799 |
12.010 | 8414 | 9688 | 15260 | 23141 |
12.320 | 2323 | 2687 | 3259 | 8851 |
13.000 | 4505 | 3036 | 5734 | 10321 |
对照(没有LA) | 含0.1%LA的脱脂乳 | |||||
LA盐 | LA+吐温80(0.01%) | LA+吐温80(0.1%) | LA+吐温80(0.2%) | LA+吐温80(0.5%) | ||
6.857 | 100 | 100 | 100 | 100 | 100 | 100 |
12.002c9t11 | 8002 | 10230 | 15846 | 13972 | 17510 | 14872 |
12.332t10c12 | 3397 | 3883 | 4154 | 4276 | 5978 | 5042 |
13.000 | 9967 | 9520 | 10312 | 11912 | 11176 | 9784 |
脱脂乳 | ||||||
RT | 没有PL62 | 对照 | 乳糖 | 果糖 | 葡萄糖 | 蔗糖 |
6.895 | 306968 | 432143 | 311253 | 330425 | 332955 | 420686 |
12.124 | 28760 | 30722 | 26172 | 30375 | 27515 | 52851 |
12.45 | 17850 | 18148 | 12821 | 19046 | 15277 | 29339 |
13.000 | 15088 | 20574 | 22464 | 18299 | 29688 | 21649 |
组 | No. | 6/11(0W) | 6/17(1W) | 6/25(2W) | 7/2(3W) | 7/9(4W) | 7/16(5W) | 7/23(6W) | 7/30(7W) | 8/6(8W) | 8/10(8.5W) |
常规饮食 | 1 | 9.8 | 14.8 | 19.9 | 21.9 | 22.5 | 23.0 | 24.2 | 23.5 | 24.3 | 24.3 |
2 | 9.0 | 12.3 | 20.8 | 21.8 | 22.8 | 23.5 | 24.2 | 25.5 | 26.8 | 26.4 | |
3 | 9.0 | 14.2 | 19.1 | 21.3 | 22.8 | 23.6 | 24.5 | 25.3 | 26.0 | 26.1 | |
4 | 9.2 | 14.6 | 19.2 | 20.9 | 21.0 | 21.9 | 23.1 | 24.5 | 24.6 | 24.4 | |
平均 | 9.5 | 14.0 | 19.8 | 21.5 | 22.3 | 23.0 | 24.0 | 24.7 | 25.4 | 25.3 | |
高脂肪饮食 | 1 | 8.9 | 16.0 | 20.9 | 22.9 | 24.0 | 26.5 | 28.7 | 31.6 | 33.6 | 34.5 |
2 | 10.1 | 16.8 | 23.5 | 23.1 | 25.8 | 27.8 | 29.8 | 33.5 | 35.8 | 36.4 | |
3 | 9.8 | 17.2 | 21.9 | 22.9 | 25.0 | 28.2 | 31.5 | 33.6 | 35.7 | 36.5 | |
4 | 9.0 | 15.7 | 24.1 | 25.0 | 27.1 | 29.5 | 31.0 | 33.4 | 35.5 | 35 | |
平均 | 9.5 | 16.4 | 22.6 | 23.5 | 25.5 | 28.0 | 30.3 | 33.0 | 35.2 | 35.6 | |
对照 | 1 | 8.2 | 14.6 | 21.4 | 23.0 | 25.2 | 27.1 | 28.5 | 30.4 | 33.1 | 33.9 |
2 | 10.0 | 17.1 | 21.2 | 22.9 | 24.1 | 25.6 | 27.7 | 31.1 | 33.7 | 33.7 | |
3 | 9.3 | 16.8 | 23.3 | 24.5 | 26.8 | 28.6 | 30.5 | 32.8 | 34.1 | 34.9 | |
4 | 10.3 | 17.3 | 22.5 | 24.1 | 26.5 | 28.0 | 30.5 | 33.3 | 34.9 | 36.0 | |
平均 | 9.5 | 16.5 | 22.1 | 23.6 | 25.7 | 27.3 | 29.3 | 31.9 | 34.0 | 34.6 | |
高脂肪+PL62(109) | 1 | 10.0 | 16.8 | 20.0 | 21.5 | 23.2 | 25.4 | 27.3 | 30.0 | 32.4 | 32.6 |
2 | 8.4 | 14.7 | 21.1 | 22.1 | 23.2 | 24.4 | 25.4 | 27.3 | 29.5 | 30.0 | |
3 | 10.2 | 17.8 | 21.0 | 21.6 | 21.9 | 23.3 | 24.6 | 26.9 | 29.3 | 31.2 | |
4 | 8.8 | 15.6 | 19.5 | 20.5 | 21.5 | 23.3 | 25.6 | 28.8 | 30.6 | 31.9 | |
平均 | 9.3 | 16.2 | 20.4 | 21.4 | 22.5 | 24.1 | 25.7 | 28.3 | 30.5 | 31.4 | |
高脂肪+PL62(107) | 1 | 9.8 | 16.6 | 20.8 | 22.6 | 23.2 | 25.0 | 25.9 | 27.7 | 29.5 | 30.4 |
2 | 9.5 | 16.4 | 21.8 | 23.2 | 25.4 | 26.7 | 27.8 | 28.8 | 29.9 | 30.6 | |
3 | 9.7 | 14.9 | 20.5 | 21.6 | 22.5 | 24.5 | 25.4 | 28.5 | 30.1 | 31.1 | |
4 | 9.9 | 16.1 | 21.2 | 22.9 | 24.1 | 25.7 | 26.5 | 28.5 | 31.4 | 33.3 | |
平均 | 9.6 | 16.0 | 21.1 | 22.6 | 23.8 | 25.5 | 26.4 | 28.4 | 30.2 | 31.4 |
肝 | 肾 | 脾 | 脑 | 肠系膜 | 肾脏边缘 | 腹股沟区 | 附睾 | |
NC | 1.07 | 0.31 | 0.05 | 0.45 | 0.20 | 0.06 | 0.12 | 0.35 |
PC | 1.18 | 0.40 | 0.07 | 0.44 | 0.58 | 0.90 | 1.69 | 2.01 |
对照 | 1.03 | 0.35 | 0.07 | 0.43 | 0.60 | 0.83 | 1.40 | 1.77 |
PL62(109) | 0.94 | 0.34 | 0.07 | 0.42 | 0.45 | 0.63 | 1.17 | 1.63 |
PL62(107) | 0.94 | 0.35 | 0.07 | 0.43 | 0.60 | 0.62 | 1.16 | 1.47 |
I.微生物的鉴定 | ||
由保藏人给予的鉴定名称:植物乳杆菌PL62 | 国际保藏单位给予的保藏编号:KCCM-10655P | |
II.科学描述和/或提出的分类名称 | ||
在以上第1项中鉴定的微生物具有:□科学描述□提出的分类名称(在相应方框内标出) | ||
III.收到和接受 | ||
该国际保藏单位接受上述第I项鉴定的微生物,其为在2005年5月9日(原始保藏日期)1接收的微生物。 | ||
IV.国际保藏单位 | ||
名称:韩国微生物培养中心地址:韩国首尔120-091西大门区弘济-1-洞儒林B/D 361-221 | 有权代表国际保藏单位的人员或权威官员的签名日期:2005年5月12日 |
Claims (14)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020040070132 | 2004-09-02 | ||
KR1020040070132A KR100686558B1 (ko) | 2004-09-02 | 2004-09-02 | 체지방 저하 기능성 락토바실러스 플랜타륨와 이를 함유한 식품 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN101044234A true CN101044234A (zh) | 2007-09-26 |
Family
ID=36000264
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA2005800294502A Pending CN101044234A (zh) | 2004-09-02 | 2005-06-30 | 具有减少身体脂肪活性的植物乳杆菌以及包含它们的食品 |
Country Status (9)
Country | Link |
---|---|
US (1) | US20080057044A1 (zh) |
EP (1) | EP1791946A4 (zh) |
JP (1) | JP2008511312A (zh) |
KR (1) | KR100686558B1 (zh) |
CN (1) | CN101044234A (zh) |
BR (1) | BRPI0515618A (zh) |
CA (1) | CA2579022C (zh) |
MX (1) | MX2007002528A (zh) |
WO (1) | WO2006025643A1 (zh) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102548566A (zh) * | 2009-10-09 | 2012-07-04 | 抗体抗生素股份有限公司 | 植物乳杆菌菌株用作降血胆固醇试剂 |
CN103314099A (zh) * | 2010-07-30 | 2013-09-18 | 株式会社明治 | 具有代谢综合症改善效果的乳酸菌 |
CN109549195A (zh) * | 2017-09-27 | 2019-04-02 | 家宝农产 | 具有抗肥胖活性的含有发酵香橙渣的食物成分 |
CN109694832A (zh) * | 2017-10-20 | 2019-04-30 | 葡萄王生技股份有限公司 | 胚芽乳酸杆菌及其降血脂、肝功指数、尿酸和抗发炎用途 |
CN111676157A (zh) * | 2020-06-05 | 2020-09-18 | 杭州娃哈哈科技有限公司 | 一种基于植物乳杆菌的组合物及其制备方法 |
CN111714572A (zh) * | 2020-06-08 | 2020-09-29 | 杭州娃哈哈科技有限公司 | 一种基于植物乳杆菌的益生菌片剂及其制备方法 |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5025930B2 (ja) * | 2005-09-13 | 2012-09-12 | 株式会社桃屋 | ラクトバチルス・プランタラムの菌体を有効成分とする体脂肪率低減剤 |
JP5036020B2 (ja) * | 2005-11-30 | 2012-09-26 | 雪印メグミルク株式会社 | 腎周囲脂肪蓄積抑制剤 |
CN101410128A (zh) | 2006-01-27 | 2009-04-15 | 丹尼斯科公司 | 益生微生物用于治疗和预防肥胖及相关病症的用途 |
WO2008029505A1 (fr) * | 2006-09-04 | 2008-03-13 | Snow Brand Milk Products Co., Ltd. | Agent d'accélération de l'accroissement et/ou la prévention de diminution dans le niveau d'adiponectine dans le sang, et inhibiteur de l'accumulation de graisse viscérale |
WO2008075949A1 (en) * | 2006-12-20 | 2008-06-26 | Friesland Brands B.V. | Modulation of human microsomal triglyceride transfer protein (mtp or mttp) gene expression by food-grade/ingested dietary microorganisms |
JP5201832B2 (ja) * | 2006-12-25 | 2013-06-05 | 花王株式会社 | 脂肪分解促進用皮膚外用剤 |
JP2008214253A (ja) * | 2007-03-02 | 2008-09-18 | Snow Brand Milk Prod Co Ltd | 内臓脂肪減少剤 |
JPWO2008120712A1 (ja) * | 2007-03-30 | 2010-07-15 | サントリーホールディングス株式会社 | 交感神経活動亢進作用を有する医薬組成物又は飲食物 |
WO2009043856A2 (en) * | 2007-10-01 | 2009-04-09 | University College Cork, National University Of Ireland, Cork | Modulation of tissue fatty acid composition of a host by human gut bacteria |
KR101010914B1 (ko) * | 2008-04-28 | 2011-01-26 | 주식회사 엔유씨전자 | 항비만 및 뇌기능개선 관련 생리활성 기능을 가지는 프로바이오틱 유산균 락토바실러스 플란타늄 |
KR101068524B1 (ko) * | 2008-07-07 | 2011-09-30 | 한국식품연구원 | 락토바실러스 프란타럼 μ23 균주를 포함하는 발효유 및이의 제조방법 |
CN101748083B (zh) * | 2008-12-11 | 2012-01-04 | 吉林省农业科学院 | 植物乳杆菌发酵剂及其制备方法与专用菌株 |
KR100996577B1 (ko) | 2009-04-01 | 2010-11-24 | 주식회사한국야쿠르트 | 혈중 콜레스테롤 강하와 비만 억제 효능을 갖는 신규의 락토바실러스 커베터스 에이취와이7601 및 이를 유효성분으로 함유하는 제품 |
WO2010117255A1 (en) * | 2009-04-09 | 2010-10-14 | Universiti Putra Malaysia (Upm) | Monogastric animal feed |
FR2955774A1 (fr) | 2010-02-02 | 2011-08-05 | Aragan | Preparation destinee a traiter l'exces ponderal et les desordres associes et applications de ladite preparation |
WO2013168310A1 (ja) * | 2012-05-10 | 2013-11-14 | 国立大学法人京都大学 | オキソ脂肪酸及び希少脂肪酸の製造法 |
KR101580732B1 (ko) * | 2013-01-31 | 2015-12-28 | 부산대학교 산학협력단 | 신규한 스타터 균주 및 이를 이용한 김치를 포함하는 기능성 발효식품의 제조방법 |
KR101566989B1 (ko) | 2014-09-03 | 2015-11-06 | 조선대학교산학협력단 | 김치로부터 분리된 콜레스테롤 저하능을 갖는 유산균 및 그의 용도 |
CN104388482B (zh) * | 2014-10-28 | 2017-07-11 | 南昌大学 | 一种利用静息乳酸菌技术转化菜油脚料生产共轭亚油酸的方法 |
KR102125548B1 (ko) | 2015-02-10 | 2020-06-24 | 주식회사 지니스 | 비만 억제능을 갖는 균주 및 이를 함유하는 약학 조성물 |
JP2018154649A (ja) * | 2018-06-08 | 2018-10-04 | 株式会社東洋新薬 | コラーゲン産生促進用組成物、コラーゲン吸収促進用組成物、抗肥満用組成物 |
TWI824127B (zh) * | 2018-12-11 | 2023-12-01 | 生合生物科技股份有限公司 | 胚芽乳酸桿菌twk10用於製備降體脂醫藥組合物之用途 |
KR102198827B1 (ko) * | 2020-07-24 | 2021-01-05 | 주식회사 리부트라이프 | 신규 락토바실러스 플란타럼 균주 및 이를 포함하는 비만 예방 또는 치료용 조성물 |
CN115960767B (zh) * | 2022-11-09 | 2024-04-26 | 厦门元之道生物科技有限公司 | 一种植物乳植杆菌及其应用 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5554646A (en) * | 1992-04-29 | 1996-09-10 | Wisconsin Alumni Research Foundation | Method for reducing body fat in animals |
US5856149A (en) | 1995-06-01 | 1999-01-05 | Wisconsin Alumni Research Foundation | Method of producing conjugated fatty acids |
US5976580A (en) * | 1995-06-07 | 1999-11-02 | Novus International, Inc. | Nutrient formulation and process for enhancing the health, livability, cumulative weight gain or feed efficiency in poultry and other animals |
WO2002089593A1 (fr) * | 2000-02-03 | 2002-11-14 | Kabushiki Kaisha Yakult Honsha | Aliments fermentes et procede de production de ces aliments |
EP1264893A1 (en) * | 2001-06-08 | 2002-12-11 | Teagasc Dairy Products Research Centre | CLA biosynthesis by bifidobacteria |
US7250226B2 (en) * | 2001-08-31 | 2007-07-31 | Nippon Hoso Kyokai | Phosphorescent compound, a phosphorescent composition and an organic light-emitting device |
AU2003221135A1 (en) * | 2002-04-12 | 2003-10-27 | Chebigen Inc. | New strains capable of producing conjugated linoleic acid, capsulated composition comprising them, and the preparation methods thereof |
ATE445707T1 (de) | 2002-04-12 | 2009-10-15 | Yakult Honsha Kk | Verfahren zur herstellung konjugierter fettsäure und mit diesem verfahren produzierte lebensmittel/getränke |
KR100470460B1 (ko) * | 2003-01-09 | 2005-02-05 | 대한민국 | 씨엘에이를 생산하는 락토바실러스 퍼멘텀 및 이를 이용한다량의 씨엘에이를 함유하는 배양액 제조방법 |
-
2004
- 2004-09-02 KR KR1020040070132A patent/KR100686558B1/ko active IP Right Grant
-
2005
- 2005-06-30 JP JP2007529665A patent/JP2008511312A/ja active Pending
- 2005-06-30 CN CNA2005800294502A patent/CN101044234A/zh active Pending
- 2005-06-30 CA CA2579022A patent/CA2579022C/en active Active
- 2005-06-30 EP EP05765924A patent/EP1791946A4/en not_active Withdrawn
- 2005-06-30 BR BRPI0515618-1A patent/BRPI0515618A/pt not_active Application Discontinuation
- 2005-06-30 US US11/661,604 patent/US20080057044A1/en not_active Abandoned
- 2005-06-30 MX MX2007002528A patent/MX2007002528A/es active IP Right Grant
- 2005-06-30 WO PCT/KR2005/002067 patent/WO2006025643A1/en active Application Filing
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102548566A (zh) * | 2009-10-09 | 2012-07-04 | 抗体抗生素股份有限公司 | 植物乳杆菌菌株用作降血胆固醇试剂 |
CN102548566B (zh) * | 2009-10-09 | 2014-07-09 | 抗体抗生素股份有限公司 | 植物乳杆菌菌株用作降血胆固醇试剂 |
CN103314099A (zh) * | 2010-07-30 | 2013-09-18 | 株式会社明治 | 具有代谢综合症改善效果的乳酸菌 |
CN103314099B (zh) * | 2010-07-30 | 2014-12-03 | 株式会社明治 | 具有代谢综合症改善效果的乳酸菌 |
CN109549195A (zh) * | 2017-09-27 | 2019-04-02 | 家宝农产 | 具有抗肥胖活性的含有发酵香橙渣的食物成分 |
CN109694832A (zh) * | 2017-10-20 | 2019-04-30 | 葡萄王生技股份有限公司 | 胚芽乳酸杆菌及其降血脂、肝功指数、尿酸和抗发炎用途 |
CN109694832B (zh) * | 2017-10-20 | 2022-04-29 | 葡萄王生技股份有限公司 | 胚芽乳酸杆菌及其降血脂、肝功指数、尿酸和抗发炎用途 |
CN111676157A (zh) * | 2020-06-05 | 2020-09-18 | 杭州娃哈哈科技有限公司 | 一种基于植物乳杆菌的组合物及其制备方法 |
CN111714572A (zh) * | 2020-06-08 | 2020-09-29 | 杭州娃哈哈科技有限公司 | 一种基于植物乳杆菌的益生菌片剂及其制备方法 |
CN111714572B (zh) * | 2020-06-08 | 2024-02-09 | 杭州娃哈哈科技有限公司 | 一种基于植物乳杆菌的益生菌片剂及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
MX2007002528A (es) | 2007-07-04 |
EP1791946A4 (en) | 2008-01-09 |
CA2579022C (en) | 2012-09-11 |
KR100686558B1 (ko) | 2007-02-23 |
US20080057044A1 (en) | 2008-03-06 |
JP2008511312A (ja) | 2008-04-17 |
KR20060021240A (ko) | 2006-03-07 |
WO2006025643A1 (en) | 2006-03-09 |
CA2579022A1 (en) | 2006-03-09 |
EP1791946A1 (en) | 2007-06-06 |
BRPI0515618A (pt) | 2008-07-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101044234A (zh) | 具有减少身体脂肪活性的植物乳杆菌以及包含它们的食品 | |
CN101068918A (zh) | 具有减少身体脂肪活性的鼠李糖乳杆菌以及包含它们的食品 | |
CN105132322B (zh) | 一株植物乳杆菌及其应用 | |
CN101541947B (zh) | 分离自母乳的具有益生菌活性和抑制体重增加活性的乳酸菌 | |
TWI241912B (en) | Novel Acid-and bile salt-resistant Lactobacillus isolates having the ability to lower and assimilate cholesterol | |
CN1342196A (zh) | 用于治疗炎性疾病的双歧杆菌 | |
CN108251335B (zh) | 一种具有乳酸活性的粪肠球菌hkf7及其筛选培养方法和应用 | |
Thwe et al. | Isolation, characterization, and utilization of γ-aminobutyric acid (GABA)-producing lactic acid bacteria from Myanmar fishery products fermented with boiled rice | |
CN102317435B (zh) | 雌马酚产生菌及其利用 | |
CN105121627B (zh) | 含有乳杆菌属菌的组合物 | |
CN1406274A (zh) | 新颖的抗幽门螺杆菌和大肠杆菌157:h7的类干酪乳杆菌类干酪亚种菌株的抗细菌剂 | |
CN110964658A (zh) | 一种具有免疫调节功能的副干酪乳杆菌et-22 | |
JP2009159955A (ja) | クルマエビ腸内から分離したプロバイオティクス乳酸菌 | |
CN114561320B (zh) | 乳酸杆菌益生菌CGMCC No.1.13855在制备肝病治疗药物中的应用 | |
KR102130646B1 (ko) | 신규한 락토바실러스 살리바리우스 및 이를 유효성분으로 포함하는 양식 어류 및 갑각류용 사료첨가제 | |
KR20160063024A (ko) | 락토바실러스 플란타룸 kcc-24 및 이를 포함하는 조성물 | |
CN105143438B (zh) | 乳杆菌属菌 | |
CN114231472B (zh) | 乳酸杆菌益生菌CGMCC No.23437及在制备降脂药物中的应用 | |
CN113755396B (zh) | 格氏乳杆菌rw2014及在制备降脂药物中的应用 | |
KR20140087518A (ko) | Gaba 생산 활성을 갖는 신규 유산균 균주 및 이의 발효 배양물을 함유하는 조성물 | |
AU2022392707A1 (en) | Bacterial strain and the use thereof | |
CN1348989A (zh) | 鼠李糖乳酸杆菌菌株及其用途 | |
Abedi et al. | Isolation and identification of Lactobacillus strains from dairy products and evaluation of carbon sources effects on bacterial growth and phytase activity: supplement for fish feed. | |
EP2367950B1 (en) | Production of omega-3 fatty acids by myxobacteria | |
JP2003012534A (ja) | 酵素活性抑制剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20080104 Address after: Seoul, South Kerean Applicant after: PL biological plant Co-applicant after: CJ Corp. Address before: Seoul, South Kerean Applicant before: PL biological plant Co-applicant before: CJ Co., Ltd. |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1112938 Country of ref document: HK |
|
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Open date: 20070926 |